deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT00760734

Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)

HBOT in Chronic Traumatic Brain Injury/Post Concussion Syndrome and TBI/PTSD Pilot Trial

Sponsor: Coalition to Support America's Heroes

Updated 6 times since 2017 Last updated: Apr 16, 2017 Started: Sep 30, 2008 Primary completion: Sep 30, 2010 Completion: Jun 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Chronic Post Traumatic Stress Disorder and Post Concussion Syndrome and is currently completed. Coalition to Support America's Heroes leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotCompleted~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Oct 2019 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jun 2018 — Oct 2019 [monthly]

    Completed PHASE1

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Coalition to Support America's Heroes
  • Marine Corps-Law Enforcement Foundation
  • Paul G. Harch, M.D.
  • Semper Fi Fund
  • Thirty-eight other contributors
Data source: Louisiana State University Health Sciences Center in New Orleans

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations